Chronic administration of CBD to healthy volunteers and epileptic patients.

Summary: In phase 1 of the study, 3 mg/kg daily of cannabidiol (CBD) was given for 30 days to 8…

3 years ago

The role of the endocannabinoid system in eating disorders

Summary: The endocannabinoid system has long been known as a modulator of several physiological functions, among which the homeostatic and…

3 years ago

Endocannabinoids: potential therapeutic targets in anorexia nervosa.

Summary: Anorexia nervosa (AN) has the highest mortality rate between psychiatric disorders, and evidence for managing it is still very…

3 years ago

CBDs in the management of difficult to treat pain.

Summary: This article reviews recent research on cannabinoid analgesia via the endocannabinoid system and non-receptor mechanisms, as well as randomized…

3 years ago

CBD is an orally effective therapeutic agent in rat chronic inflammatory and neuropathic pain.

Summary: Cannabidiol, the major psycho-inactive component of cannabis, has substantial anti-inflammatory and immunomodulatory effects. This study investigated its therapeutic potential…

3 years ago

CBD for neuropathic pain.

Summary: Treatment options for neuropathic pain have limited efficacy and use is fraught with dose-limiting adverse effects. The endocannabinoid system…

3 years ago

Meta-analysis of cannabis based treatments for neuropathic and multiple sclerosis-related pain.

Summary: OBJECTIVE: Debilitating pain, occurring in 50-70% of multiple sclerosis (MS) patients, is poorly understood and infrequently studied. We summarized…

3 years ago

Chemopreventive effect of CBD on experimental colon cancer.

Summary: Colon cancer affects millions of individuals in Western countries. Cannabidiol, a safe and non-psychotropic ingredient of Cannabis sativa, exerts…

3 years ago